A new trading day began on Tuesday, with Omega Therapeutics Inc (NASDAQ: OMGA) stock price down -68.69% from the previous day of trading, before settling in for the closing price of $0.48. OMGA’s price has ranged from $0.44 to $4.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 347.21% over the last five years. Meanwhile, its annual earnings per share averaged 35.28%. With a float of $19.33 million, this company’s outstanding shares have now reached $55.16 million.
The firm has a total of 94 workers. Let’s measure their productivity. In terms of profitability, gross margin is -59.81%, operating margin of -916.0%, and the pretax margin is -902.93%.
Omega Therapeutics Inc (OMGA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Omega Therapeutics Inc is 65.08%, while institutional ownership is 23.79%.
Omega Therapeutics Inc (OMGA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 35.28% per share during the next fiscal year.
Omega Therapeutics Inc (NASDAQ: OMGA) Trading Performance Indicators
Here are Omega Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.33, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.79 in one year’s time.
Technical Analysis of Omega Therapeutics Inc (OMGA)
Analysing the last 5-days average volume posted by the [Omega Therapeutics Inc, OMGA], we can find that recorded value of 2.99 million was better than the volume posted last year of 1.26 million. As of the previous 9 days, the stock’s Stochastic %D was 13.40%. Additionally, its Average True Range was 0.10.
During the past 100 days, Omega Therapeutics Inc’s (OMGA) raw stochastic average was set at 0.74%, which indicates a significant decrease from 2.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 476.06% in the past 14 days, which was higher than the 208.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7418, while its 200-day Moving Average is $1.4481. Now, the first resistance to watch is $0.3385. This is followed by the second major resistance level at $0.5270. The third major resistance level sits at $0.6270.
Omega Therapeutics Inc (NASDAQ: OMGA) Key Stats
With a market capitalization of 8.31 million, the company has a total of 55,366K Shares Outstanding. Currently, annual sales are 3,090 K while annual income is -97,430 K. The company’s previous quarter sales were 2,610 K while its latest quarter income was -16,440 K.
